We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
This study reported high prevalence, especially of undiagnosed cases amongst adults, most have uncontrolled blood sugar levels
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
We remind healthcare professionals that accidental use of glucose-containing solutions as flush fluid for arterial lines may contaminate blood samples and result in falsely high glucose readings. This may lead to inappropriate insulin administration and subsequent hypoglycaemia. Healthcare professionals should...
An overview of the NHS diabetic eye screening (DES) programme, its services and contact information.
You must tell DVLA if you have hypoglycaemia - download the correct form to let them know
Projects granted during 2016 that have a primary purpose of basic research, endocrine system / metabolism.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices and a reminder of a recent MHRA National Patient Safety Alert to highlight the potential risk of underdosing with calcium gluconate in severe hyperkalaemia....
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
Data analysis was performed using the chi-square test and multivariate logistic regression
Cutaneous amyloidosis at the injection site has been reported in patients using insulin and this may affect glycaemic control. Remind patients to rotate injection sites within the same body region.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.